Prevention: An aspirin a day keeps the CRC at bay in Lynch syndrome

Nature Reviews Clinical Oncology 12, 562 (2015). doi:10.1038/nrclinonc.2015.148 Whether adiposity is a risk factor for the development of hereditary colorectal cancer (CRC) in patients with Lynch syndrome is unclear. In a prospective study, 937 patients were randomly assigned to receive daily aspirin (600 mg) or placebo. The CRC risk was greater in obese
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Tags: Research Highlight Source Type: research